Minapharm Pharmaceuticals (CAI:MIPH) Change In Receivables : E£0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Change In Receivables?

Minapharm Pharmaceuticals's change in receivables for the quarter that ended in Sep. 2024 was E£0 Mil. It means Minapharm Pharmaceuticals's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Minapharm Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2023 was E£-153 Mil. It means Minapharm Pharmaceuticals's Accounts Receivable increased by E£153 Mil from Dec. 2022 to Dec. 2023 .

Minapharm Pharmaceuticals's Accounts Receivable for the quarter that ended in Sep. 2024 was E£464 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Minapharm Pharmaceuticals's Days Sales Outstanding for the three months ended in Sep. 2024 was 28.01.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Minapharm Pharmaceuticals's liquidation value for the three months ended in Sep. 2024 was E£-6,164 Mil.

Minapharm Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Minapharm Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Change In Receivables Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

Change In Receivables

-175.21

-152.62

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-

Minapharm Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£0 Mil.

Minapharm Pharmaceuticals (CAI:MIPH) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Minapharm Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	464.34	/	1512.966	*	91
=	28.01

2. In Ben Graham's calculation of liquidation value, Minapharm Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Minapharm Pharmaceuticals's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	231.086	-	7381.744	+	0.75 * 464.34	+	0.5 * 1275.909
=	-6,164

Minapharm Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

https://www.minapharm.com

Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines